litlas
Log inCreate account

Peter B. Berger

Active 1990–2023

118
Papers
35,134
Citations
97
h-index
118
i10-index

Citations

Citations per year for Peter B. Berger1971: 1 citations1981: 1 citations1983: 1 citations1985: 1 citations1986: 1 citations1989: 1 citations1990: 1 citations1991: 1 citations1992: 4 citations1993: 4 citations1994: 7 citations1995: 7 citations1996: 19 citations1997: 25 citations1998: 31 citations1999: 50 citations2000: 59 citations2001: 90 citations2002: 91 citations2003: 159 citations2004: 260 citations2005: 346 citations2006: 381 citations2007: 380 citations2008: 346 citations2009: 325 citations2010: 305 citations2011: 358 citations2012: 304 citations2013: 235 citations2014: 252 citations2015: 183 citations2016: 160 citations2017: 149 citations2018: 124 citations2019: 390 citations2020: 337 citations2021: 294 citations2022: 212 citations2023: 137 citations2024: 202 citations2025: 78 citations2026: 2 citations1972–1980: no citations, so these years are not shown1982: no citations, so this year is not shown1984: no citations, so this year is not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,545 citing papers, 29.3% of this breakdownUnited Kingdom: 665 citing papers, 7.6% of this breakdownGermany: 536 citing papers, 6.2% of this breakdownItaly: 495 citing papers, 5.7% of this breakdownCanada: 484 citing papers, 5.6% of this breakdownNetherlands: 361 citing papers, 4.1% of this breakdownFrance: 358 citing papers, 4.1% of this breakdownChina: 304 citing papers, 3.5% of this breakdownJapan: 226 citing papers, 2.6% of this breakdownAustralia: 217 citing papers, 2.5% of this breakdownSpain: 198 citing papers, 2.3% of this breakdownSwitzerland: 188 citing papers, 2.2% of this breakdown
0%29.3%Other 24.3%

Institutions

Fields

  • Medicine85%
  • Biochemistry, Genetics and Molecular Biology4.5%
  • Immunology and Microbiology3%
  • Engineering2.4%
  • Neuroscience0.8%
  • Social Sciences0.7%
  • Other3.6%

Topics

  • Acute Myocardial Infarction Research8.9%
  • Antiplatelet Therapy and Cardiovascular Diseases8%
  • Coronary Interventions and Diagnostics7.3%
  • Cardiac Imaging and Diagnostics5%
  • Atrial Fibrillation Management and Outcomes3%
  • Acute Kidney Injury Research2.5%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Plasma Ceramides

    Authors: Jeffrey W. Meeusen, Leslie J. Donato, Sandra C. Bryant, Linnea M. Baudhuin, Peter B. Berger, Allan S. Jaffe - Arteriosclerosis Thrombosis and Vascular Biology 2018 cited by 233

  2. Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease

    Authors: Sotirios Tsimikas, Emmanouil S. Brilakis, Elizabeth R. Miller, Joseph P. McConnell, Ryan J. Lennon, Kenneth S. Kornman, Joseph L. Witztum, Peter B. Berger - New England Journal of Medicine 2005 cited by 768

  3. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention

    Authors: Charanjit S. Rihal, Stephen C. Textor, Diane E. Grill, Peter B. Berger, Henry H. Ting, Patricia J.M. Best, Mandeep Singh, Malcolm R. Bell, Gregory W. Barsness, Verghese Mathew, Kirk N. Garratt, David R. Holmes - Circulation 2002 cited by 1,723

  4. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden

    Authors: Leslee J. Shaw, Daniel S. Berman, David J. Maron, G.B. John Mancini, Sean W. Hayes, Pamela Hartigan, William S. Weintraub, Robert A. O’Rourke, Marcin Dada, John A. Spertus, Bernard Chaitman, John D. Friedman, Piotr J. Slomka, Gary V. Heller, Guido Germano, Gilbert Gosselin, Peter B. Berger, William J. Kostuk, Ronald G. Schwartz, Merill L Knudtson, Emir Veledar, Eric Bates, Benjamin D. McCallister, Koon Teo, William E. Boden - Circulation 2008 cited by 1,601

  5. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis

    Authors: Shanshan Chu, Richard C. Becker, Peter B. Berger, Deepak L. Bhatt, John W. Eikelboom, Barbara A. Konkle, Emile R. Mohler, Muredach P. Reilly, Jeffrey S. Berger - Journal of Thrombosis and Haemostasis 2009 cited by 1,048

  6. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

    Authors: Steven R. Steinhubl, Peter B. Berger, J. Tift Mann, Edward T.A. Fry, Augustin DeLago, Charles Wilmer, Eric J. Topol, for the CREDO Investigators - JAMA 2002 cited by 3,083

  7. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

    Authors: Sotirios Tsimikas, Emmanouil S. Brilakis, Ryan J. Lennon, Elizabeth R. Miller, Joseph L. Witztum, Joseph P. McConnell, Kenneth S. Kornman, Peter B. Berger - Journal of Lipid Research 2006 cited by 261

  8. Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease

    Authors: Paul Sorajja, Steve R. Ommen, Rick A. Nishimura, Bernard J. Gersh, Peter B. Berger, A. Jamil Tajik - Circulation 2003 cited by 196

  9. Pro-Inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a)

    Authors: Sotirios Tsimikas, Gordon W. Duff, Peter B. Berger, John Rogus, Kenneth Huttner, Paul Clopton, Emmanouil S. Brilakis, Kenneth S. Kornman, Joseph L. Witztum - Journal of the American College of Cardiology 2014 cited by 138

  10. Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction

    Authors: Peter B. Berger, Stephen G. Ellis, David R. Holmes, Christopher B. Granger, Douglas A. Criger, Amadeo Betriu, Eric J. Topol, Robert M. Califf - Circulation 1999 cited by 577

  11. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

    Authors: Roxana Mehran, Usman Baber, Philippe Gabríel Steg, Cono Ariti, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna Kini, Thomas Stuckey, David J. Cohen, Peter B. Berger, Ιoannis Iakovou, George Dangas, Ron Waksman, David Antoniucci, Samantha Sartori, Mitchell W. Krucoff, James Hermiller, Fayaz A. Shawl, C. Michael Gibson, Alaide Chieffo, Maria Alu, David J. Moliterno, Antonio Colombo, Stuart Pocock - The Lancet 2013 cited by 613

  12. Bleeding Complications With Dual Antiplatelet Therapy Among Patients With Stable Vascular Disease or Risk Factors for Vascular Disease

    Authors: Peter B. Berger, Deepak L. Bhatt, Valentı́n Fuster, Philippe Gabríel Steg, Keith A.A. Fox, Mingyuan Shao, Danielle M. Brennan, Werner Hacke, Gilles Montalescot, Steven R. Steinhubl, Eric J. Topol - Circulation 2010 cited by 233

  13. The Relative Efficacy and Safety of Clopidogrel in Women and Men

    Authors: Jeffrey S. Berger, Deepak L. Bhatt, Christopher P. Cannon, Zhengming Chen, Lixin Jiang, James B. Jones, Shamir R. Mehta, Marc S. Sabatine, Steven R. Steinhubl, Eric J. Topol, Peter B. Berger - Journal of the American College of Cardiology 2009 cited by 140

  14. Impact of Regionalization of ST-Segment–Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services–Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention

    Authors: James G. Jollis, Hussein R. Al‐Khalidi, Mayme L. Roettig, Peter B. Berger, Claire C. Corbett, Shannon M. Doerfler, Christopher B. Fordyce, Timothy D. Henry, Lori Hollowell, Zainab Magdon-Ismail, Ajar Kochar, James J. McCarthy, Lisa Monk, Peter K. O’Brien, Thomas D. Rea, Jay Shavadia, Jacqueline Tamis‐Holland, B. Hadley Wilson, Khaled M. Ziada, Christopher B. Granger - Circulation 2017 cited by 138

  15. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery—Executive Summary

    Authors: Kim A. Eagle, Peter B. Berger, Hugh Calkins, Bernard Chaitman, Gordon A. Ewy, Kirsten E. Fleischmann, Lee A. Fleisher, James B. Froehlich, Richard J. Gusberg, Jeffrey A. Leppo, Thomas Ryan, Robert C. Schlant, William L. Winters, Raymond J. Gibbons, Elliott M. Antman, Joseph S. Alpert, David P. Faxon, Valentı́n Fuster, Gabriel Gregoratos, Alice K. Jacobs, Loren F. Hiratzka, Richard O. Russell, Sidney C. Smith - Anesthesia & Analgesia 2002 cited by 1,690

  16. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine β-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation

    Authors: Hong Wang, Xiaohua Jiang, Fan Yang, John W. Gaubatz, Lang Ma, Mark J Magera, Xiao-Feng Yang, Peter B. Berger, William Durante, Henry J. Pownall, Andrew I. Schafer - Blood 2003 cited by 180

  17. The Social Construction of Reality

    Authors: Peter B. Berger, Thomas Luckmann - Social Theory Re-Wired 2023 cited by 1,461

  18. Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage Among Individuals With Associated Diagnosis of Atrial Fibrillation

    Authors: Jonathan Thigpen, Chrisly Dillon, Kristen Forster, Lori Henault, Emily Quinn, Yorghos Tripodis, Peter B. Berger, Elaine M. Hylek, Nita A. Limdi - Circulation Cardiovascular Quality and Outcomes 2015 cited by 133

  19. Percutaneous Coronary Intervention With and Without Intravascular Ultrasound for Patients With Complex Lesions: Utilization, Mortality, and Target Vessel Revascularization

    Authors: Edward L. Hannan, Zhong Ye, Pavan Reddy, Alice K. Jacobs, Frederick S. Ling, Spencer B. King, Peter B. Berger, Ferdinand J. Venditti, Gary Walford, Jacqueline E. Tamis‐Holland - Circulation Cardiovascular Interventions 2022 cited by 69

  20. Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

    Authors: Deepak L. Bhatt, Marcus Flather, Werner Hacke, Peter B. Berger, Henry R. Black, William E. Boden, P. Cacoub, Eric A. Cohen, Mark A. Creager, J. Donald Easton, Christian W. Hamm, Graeme J. Hankey, S. Claiborne Johnston, Koon‐Hou Mak, Jean‐Louis Mas, Gilles Montalescot, Thomas A. Pearson, Philippe Gabríel Steg, Steven R. Steinhubl, Michael A. Weber, Liz Fabry-Ribaudo, Tingfei Hu, Eric J. Topol, Keith A.A. Fox - Journal of the American College of Cardiology 2007 cited by 804

  21. Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

    Authors: Gjin Ndrepepa, Peter B. Berger, Julinda Mehilli, Melchior Seyfarth, Franz‐Josef Neumann, Albert Schömig, Adnan Kastrati - Journal of the American College of Cardiology 2008 cited by 472

  22. Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction

    Authors: Ronnier J. Aviles, Arman T. Askari, Bertil Lindahl, Lars Wallentin, Gang Jia, E. Magnus Ohman, Kenneth W. Mahaffey, L. Kristin Newby, Robert M. Califf, Maarten L. Simoons, Eric J. Topol, Peter B. Berger, Michael S. Lauer - New England Journal of Medicine 2002 cited by 348

  23. Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans

    Authors: Abu Shamsuzzaman, Mikołaj Winnicki, Robert Wołk, Anna Svatikova, Bradley G. Phillips, Diane E. Davison, Peter B. Berger, Virend K. Somers - Circulation 2004 cited by 262

  24. Regional Systems of Care Demonstration Project

    Authors: James G. Jollis, Hussein R. Al‐Khalidi, Mayme L. Roettig, Peter B. Berger, Claire C. Corbett, Harold L. Dauerman, Christopher B. Fordyce, Kathleen Fox, J. Lee Garvey, Tammy Gregory, Timothy D. Henry, Ivan C. Rokos, Matthew W. Sherwood, Robert E. Suter, B. Hadley Wilson, Christopher B. Granger - Circulation 2016 cited by 98